A novel SOS1 mutation in Costello/CFC syndrome affects signaling in both RAS and PI3K pathways

作者：Tumurkhuu Munkhtuya; Saitoh Makiko^*; Takita Junko; Mizuno Yoko; Mizuguchi Masashi

来源：Journal of Receptors and Signal Transduction, 2013, 33(2): 124-128.

DOI：10.3109/10799893.2013.779279

• Costello syndrome
• noonan syndrome
• PI3K/AKT pathway
• RAS/MAPK pathway
• SOS1

Context: Pathological upregulation of the RAS/MAPK pathway causes Costello, Noonan and cardio-facio-cutaneous (CFC) syndrome; however, little is known about PI3K/AKT signal transduction in these syndromes. Previously, we found a novel mutation of the SOS1 gene (T158A) in a patient with Costello/CFC overlapping phenotype. Objective: The aim of this study was to investigate how this mutation affects RAS/MAPK as well as PI3K/AKT pathway signal transduction.
Materials and methods: Wild-type and mutant (T158A) Son of Sevenless 1 (SOS1) were transfected into 293T cells. The levels of phospho- and total ERK1/2, AKT, p70S6K and pS6 were examined under epidermal growth factor (EGF) stimulation. Results: After EGF stimulation, the ratio of phospho- ERK1/2 to total ERK1/2 was highest at 5 min in mutant (T158A) SOS1 cells, and at 15 min in wild-type SOS1 cells. Phospho-AKT was less abundant at 60 min in mutant than in wild-type SOS1 cells. Phosphorylation at various sites in p70S6K differed between wild-type and mutant cells. Eighteen hours after activation by EGF, the ratio of phospho- ERK1/2 to total ERK1/2 remained significantly higher in mutant than in wild-type SOS1 cells, but that of phospho- AKT to total AKT was unchanged. Discussion: T158A is located in the histone-like domain, which may have a role in auto-inhibition of RAS exchanger activity of SOS1. T158A may disrupt autoinhibition and enhance RAS signaling. T158A also affects PI3K/AKT signaling, probably via negative feedback via phospho- p70S6K. Conclusion: The SOS1 T158A mutation altered the phosphorylation of gene products involved in both RAS/MAPK and PI3K/AKT pathways.

• 出版日期2013-4